Pnc Financial Services Group, Inc. Zentalis Pharmaceuticals, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $190 Billion
- Q1 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 616 shares of ZNTL stock, worth $739. This represents 0.0% of its overall portfolio holdings.
Number of Shares
616
Previous 150
310.67%
Holding current value
$739
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ZNTL
# of Institutions
140Shares Held
60.7MCall Options Held
7.9KPut Options Held
42.5K-
Matrix Capital Management Company, LP Waltham, MA14MShares$16.8 Million6.94% of portfolio
-
Black Rock Inc. New York, NY4.82MShares$5.78 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.26MShares$3.91 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.07MShares$3.68 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.67MShares$3.21 Million0.01% of portfolio
About Zentalis Pharmaceuticals, Inc.
- Ticker ZNTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,983,600
- Market Cap $68.4M
- Description
- Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...